Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Buy
53
CCEP Quote, Financials, Valuation and Earnings
Last price:
$86.19
Seasonality move
:
4.11%
Day range:
$84.95 - $86.40
52-week range:
$65.94 - $88.39
Dividend yield:
2.42%
P/E ratio:
26.13x
P/S ratio:
1.82x
P/B ratio:
4.49x
Volume:
2.2M
Avg. volume:
3.2M
1-year change:
20.64%
Market cap:
$39.6B
Revenue:
$22.1B
EPS (TTM):
$3.30
Analysts' Opinion
-
Consensus RatingCoca-Cola Europacific Partners PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $90.77, Coca-Cola Europacific Partners PLC has an estimated upside of 5.23% from its current price of $86.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $65.72 representing 23.81% downside risk from its current price of $86.26.
Fair Value
-
According to the consensus of 10 analysts, Coca-Cola Europacific Partners PLC has 5.23% upside to fair value with a price target of $90.77 per share.
CCEP vs. S&P 500
-
Over the past 5 trading days, Coca-Cola Europacific Partners PLC has overperformed the S&P 500 by 0.36% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Coca-Cola Europacific Partners PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Coca-Cola Europacific Partners PLC has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Coca-Cola Europacific Partners PLC reported revenues of --.
Earnings Growth
-
Coca-Cola Europacific Partners PLC earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Coca-Cola Europacific Partners PLC reported earnings per share of --.
Enterprise value:
49.4B
EV / Invested capital:
2.42x
Price / LTM sales:
1.82x
EV / EBIT:
21.18x
EV / Revenue:
2.26x
PEG ratio (5yr expected):
2.05x
EV / Free cash flow:
22.87x
Price / Operating cash flow:
15.22x
Enterprise value / EBITDA:
14.83x
Gross Profit (TTM):
$7.7B
Return On Assets:
4.6%
Net Income Margin (TTM):
6.94%
Return On Equity:
16.39%
Return On Invested Capital:
7.24%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2022-05-31 | 2023-05-31 | |
| Income Statement | ||||||
| Revenue | $3.2B | $1.2M | $1.6M | $330K | $510K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5B | $6.5B | $7B | $7.3B | $6.9B | |
| Total Assets | $23.7B | $32.9B | $31.4B | $32.3B | $32.4B | |
| Current Liabilities | $5.1B | $6.9B | $7.8B | $8B | $8.5B | |
| Total Liabilities | $16.3B | $24.8B | $23.4B | $23.5B | $23B | |
| Total Equity | $7.4B | $8.2B | $8B | $8.8B | $9.3B | |
| Total Debt | $8.4B | $14.1B | $12B | $11.8B | $11.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2017-12-31 | 2018-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $506.1M | $481.4M | |
| Cash From Investing | -- | -- | -- | -$214.1M | -$318.9M | |
| Cash From Financing | -- | -- | -- | -$420.6M | -$368.1M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CCEP
Sector
Market Cap
$39.6B
$281.4M
Price % of 52-Week High
97.6%
73.03%
Dividend Yield
2.42%
0%
Shareholder Yield
--
3.01%
1-Year Price Total Return
20.64%
-11.7%
Beta (5-Year)
0.922
0.459
Dividend yield:
2.42%
Annualized payout:
$2.09
Payout ratio:
--
Growth streak:
4 years
Technicals
8-day SMA
Buy
Level
$85.16
200-day SMA
Buy
Level
$77.94
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$84.73
Relative Strength Index (RSI14)
Buy
Level
59.90
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-12.7159
50-day SMA
Buy
Level
$81.99
MACD (12, 26)
Buy
Level
0.71
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
--
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1848)
Sell
CA Score
(Annual)
Level (-0.9114)
Buy
Beneish M-Score
(Annual)
Level (-2.7449)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.4164)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and South-East Asia.In 2024, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume. Coke’s largest bottler, Coca-Cola Femsa sold over 4 billion unit cases (12%), and the third-largest, Coca-Cola HBC, serving Eastern Europe and North Africa, sold 2.8 billion unit cases (8%).TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.
Stock Forecast FAQ
In the current month, CCEP has received 8 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CCEP average analyst price target in the past 3 months is $90.77.
-
Where Will Coca-Cola Europacific Partners PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Coca-Cola Europacific Partners PLC share price will rise to $90.77 per share over the next 12 months.
-
What Do Analysts Say About Coca-Cola Europacific Partners PLC?
Analysts are divided on their view about Coca-Cola Europacific Partners PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Coca-Cola Europacific Partners PLC is a Sell and believe this share price will drop from its current level to $65.72.
-
What Is Coca-Cola Europacific Partners PLC's Price Target?
The price target for Coca-Cola Europacific Partners PLC over the next 1-year time period is forecast to be $90.77 according to 10 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is CCEP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Coca-Cola Europacific Partners PLC is a Buy. 8 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CCEP?
You can purchase shares of Coca-Cola Europacific Partners PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Coca-Cola Europacific Partners PLC shares.
-
What Is The Coca-Cola Europacific Partners PLC Share Price Today?
Coca-Cola Europacific Partners PLC was last trading at $86.19 per share. This represents the most recent stock quote for Coca-Cola Europacific Partners PLC. Yesterday, Coca-Cola Europacific Partners PLC closed at $86.26 per share.
-
How To Buy Coca-Cola Europacific Partners PLC Stock Online?
In order to purchase Coca-Cola Europacific Partners PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Super Micro Stock Fall So Much?
Super Micro Computer (NASDAQ:SMCI) was once a highly popular stock…
Is Diamondback Energy a Good Stock to Buy?
Diamondback Energy (FANG) is a lesser-known diamond in the rough…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is up 42.45% over the past day.
Buy
74
SLNO alert for Mar 27
Soleno Therapeutics [SLNO] is up 37.64% over the past day.
Buy
68
WOR alert for Mar 27
Worthington Enterprises [WOR] is up 0.16% over the past day.
